Kim Steele, Sonia Parmar and Stéphane Lévesque made statements and answered questions.

Sonia Sidhu moved, — That, pursuant to Standing Order 108(2), given the growth of Artificial Intelligence in health care, the committee undertake a study of no less than six meetings on the adoption of Artificial Intelligence in health care, especially in research and innovation, data collection, health service, and patient-centered care; that the committee report its findings and recommendations to the House; and that, pursuant to Standing Order 109, the Government table a comprehensive response.

Debate arose thereon.

At 4:21 p.m., the meeting was suspended.

At 4:35 p.m., the meeting resumed.

The debate resumed on the motion of Sonia Sidhu.

The debate continued on the amendment of Burton Bailey.

Matt Strauss moved, — That the committee resume consideration of the business of the day and proceed to hear from witnesses.

At 5:08 p.m., the meeting was suspended.

At 5:10 p.m., the meeting resumed.

The question was put on the motion and it was negatived on the following recorded division:

YEAS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5;

NAYS: Helena Jaczek, Ginette Lavack, Aslam Rana, Jake Sawatzky, Sonia Sidhu, Kristina Tesser Derksen — 6.

The debate continued on the amendment of Burton Bailey.

Matt Strauss raised a potential question of privilege regarding the apparent provision of deliberately misleading information to the House by the minister; on the grounds that the statements of the minister in the House are directly contradictory with the testimony made by a witness before the Committee.

At 5:18 p.m., the meeting was suspended.

At 5:39 p.m., the meeting resumed.

The Chair reserved his decision.

At 5:40 p.m., the meeting was suspended.

At 3:43 p.m., on Tuesday, May 26, 2026,the meeting resumed in public.

The committee resumed consideration of the study of Canada's pharmaceutical sovereignty and the point of privilege raised by Matt Strauss on Thursday, May 7, 2026.

RULING BY THE CHAIR

The Chair ruled that the matter does not relate to privilege.

Whereupon, Dan Mazier appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was sustained on the following recorded division:

YEAS: Chris Bittle, Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Sonia Sidhu — 6;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5.

The debate continued on the motion of Sonia Sidhu moved on Thursday, May 7, 2026, which read as follows:

That, pursuant to Standing Order 108(2), given the growth of Artificial Intelligence in health care, the committee undertake a study of no less than six meetings on the adoption of Artificial Intelligence in health care, especially in research and innovation, data collection, health service, and patient-centered care; that the committee report its findings and recommendations to the House; and that, pursuant to Standing Order 109, the Government table a comprehensive response.

and of the amendment of Burton Bailey moved on Thursday, May 7, 2026, which read as follows:

That the motion be amended by adding after the words “and patient-centered care;” the following: “that this study does not begin until Michael Green, former CEO of Canada Health Infoway, appears for two hours on PrescribeIT;”.

At 3:59 p.m., the meeting was suspended.

At 4:03 p.m., the meeting resumed.

Burton Bailey raised a potential question of privilege regarding the apparent provision of deliberately misleading information to the committee by witnesses, on the grounds that the testimonies of the said witnesses were directly contradictory.

RULING BY THE CHAIR

The Chair ruled that the matter does not relate to privilege.

Whereupon, Dan Mazier appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was sustained on the following recorded division:

YEAS: Jaime Battiste, Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Sonia Sidhu — 6;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5.

The debate continued on the motion of Sonia Sidhu and the amendment of Burton Bailey.

Sonia Sidhu moved, — That the debate be now adjourned.

The question was put on the motion and it was agreed to on the following recorded division:

YEAS: Jaime Battiste, Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Sonia Sidhu — 6;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5.

At 4:22 p.m., the meeting was suspended.

At 4:27 p.m., the meeting resumed.

Doug Eyolfson moved, — That, pursuant to Standing Order 108(2), the committee undertake an urgent study on the rising rates of HIV infections in Canada, with particular attention to the recent declaration of a public health emergency by the Province of Manitoba related to the spread of HIV, including the disproportionate impacts on Indigenous peoples, women, rural and northern communities, and individuals experiencing homelessness, mental health challenges, and substance use disorders;

That the study examine federal programs, funding, prevention strategies, access to testing and treatment, harm reduction initiatives, public awareness efforts, and intergovernmental coordination related to HIV prevention, care, and support services;

That the committee hold no fewer than two meetings on this subject;

That witnesses include officials from the Public Health Agency of Canada, representatives from Manitoba Health, Indigenous health organizations, front-line community organizations, medical and public health experts, and individuals with lived experience;

At 4:35 p.m., the meeting was suspended.

At 4:47 p.m., the meeting resumed.

RULING BY THE CHAIR

The chair ruled the amendment inadmissible as irrelevant to the main motion because it deals with a matter foreign to the main motion.

Whereupon, Dan Mazier appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was sustained on the following recorded division:

YEAS: Jaime Battiste, Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Sonia Sidhu — 6;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5.

The debate continued on the motion of Doug Eyolfson.

At 4:55 p.m., the meeting was suspended.

At 5:08 p.m., the meeting resumed.

RULING BY THE CHAIR

The chair ruled the amendment inadmissible

The debate continued on the motion of Doug Eyolfson.

At 5:15 p.m., the meeting was suspended.

At 5:21 p.m., the meeting resumed.

The debate continued on the amendment of Sonia Sidhu.

At 5:24 p.m., the meeting was suspended.

At 5:26 p.m., the meeting resumed.

The debate continued on the amendment of Sonia Sidhu.

The debate continued on the motion of Doug Eyolfson, as amended.

RULING BY THE CHAIR

The chair ruled the amendment inadmissible as irrelevant to the main motion because it deals with a matter foreign to the main motion.

The debate continued on the motion of Doug Eyolfson, as amended.

The debate continued on the motion of Doug Eyolfson, as amended.

The debate continued on the motion of Doug Eyolfson, as amended.

At 5:57 p.m., the meeting was suspended.

At 3:34 p.m., on Thursday May 28, 2026, the meeting resumed in public.

The committee resumed consideration of the study of Canada's pharmaceutical sovereignty and the motion, as amended, of Doug Eyolfson moved on Tuesday, May 26, 2026, which read as follows:

That, pursuant to Standing Order 108(2), the committee undertake an urgent study on the rising rates of HIV infections in Canada, with particular attention to the recent declaration of a public health emergency by the Province of Manitoba related to the spread of HIV and Syphilis, including the disproportionate impacts in specific regions and populations, including 2SLGBTQI+ communities, on Indigenous peoples, women, rural and northern communities, and individuals experiencing homelessness, mental health challenges, and substance use disorders;

That the study examine federal programs, funding, prevention strategies, access to testing and treatment, harm reduction initiatives, public awareness efforts, and intergovernmental coordination related to HIV prevention, care, and support services;

That the committee hold no fewer than two meetings on this subject;

That witnesses include officials from the Public Health Agency of Canada, representatives from Manitoba Health, Indigenous health organizations, front-line community organizations, medical and public health experts, and individuals with lived experience;

And that the committee report its findings and recommendations to the House.

and the amendment of Matt Strauss moved on Tuesday, May 26, 2026, which read as follows:

That the motion be amended by adding at the end of the motion, the following: “whereas e-prescription services held the promise of improving prescribing practices as pertains to HIV medicines, that Michael Green, the former and chief executive officer of Canada Health Infoway, appear before the committee during the study for no less than two hours to testify on his role in the implementation and oversight of the Liberal government's failed $300 million PrescribeIT program.”.

RULING BY THE CHAIR

The chair ruled the amendment inadmissible as irrelevant to the main motion because it deals with a matter foreign to the main motion.

Whereupon, Matt Strauss appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was sustained on the following recorded division:

YEAS: Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Jake Sawatzky, Sonia Sidhu — 6;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Dan Mazier, Alex Ruff, Matt Strauss — 5.

The debate continued on the motion of Doug Eyolfson, as amended.

At 4:47 p.m., the meeting was suspended.

At 4:57 p.m., the meeting resumed.

At 4:58 p.m., the meeting was suspended.

At 5:01 p.m., the meeting resumed.

Debate arose on the subamendment of Matt Strauss.

The debate continued on the amendment of Dan Mazier.

At 5:19 p.m., the meeting was suspended.

At 5:20 p.m., the meeting resumed.

RULING BY THE CHAIR

The chair ruled the subamendment inadmissible.

Whereupon, Jacob Mantle appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was sustained on the following recorded division:

YEAS: Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Jake Sawatzky, Sonia Sidhu — 6;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Jacob Mantle, Dan Mazier, Matt Strauss — 5.

The debate continued on the amendment of Dan Mazier.

At 5:43 p.m., the meeting was suspended.

At 3:34 p.m., on Tuesday, June 2, 2026, the meeting resumed in public.

The committee resumed consideration of the study of Canada's pharmaceutical sovereignty.

It has been moved that the committee proceed to the consideration of the subject matter of the request received pursuant to Standing Order 106(4).

The question was put, and it was negatived on the following recorded division:

YEAS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5;

NAYS: Karim Bardeesy, Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Sonia Sidhu — 6.

The committee resumed consideration of the study of Canada's pharmaceutical sovereignty and the motion, as amended, of Doug Eyolfson moved on Tuesday, May 26, 2026, which read as follows:

That, pursuant to Standing Order 108(2), the committee undertake an urgent study on the rising rates of HIV infections in Canada, with particular attention to the recent declaration of a public health emergency by the Province of Manitoba related to the spread of HIV and Syphilis, including the disproportionate impacts in specific regions and populations, including 2SLGBTQI+ communities, Indigenous peoples, women, rural and northern communities, and individuals experiencing homelessness, mental health challenges, and substance use disorders;

That the study examine federal programs, funding, prevention strategies, access to testing and treatment, harm reduction initiatives, public awareness efforts, and intergovernmental coordination related to HIV prevention, care, and support services;

That the committee hold no fewer than two meetings on this subject;

That witnesses include officials from the Public Health Agency of Canada, representatives from Manitoba Health, Indigenous health organizations, front-line community organizations, medical and public health experts, and individuals with lived experience;

And that the committee report its findings and recommendations to the House.

and of the amendment of Dan Mazier moved on Thursday, May 28, 2026, which read as follows:

That the motion be amended by adding after the words “Public Health Agency of Canada” the following: “The Minister of Health”.

The debate continued on the motion of Doug Eyolfson as amended which read as follows:

That, pursuant to Standing Order 108(2), the committee undertake an urgent study on the rising rates of HIV infections in Canada, with particular attention to the recent declaration of a public health emergency by the Province of Manitoba related to the spread of HIV and Syphilis, including the disproportionate impacts in specific regions and populations, including 2SLGBTQI+ communities, Indigenous peoples, women, rural and northern communities, and individuals experiencing homelessness, mental health challenges, and substance use disorders;

That the study examine federal programs, funding, prevention strategies, access to testing and treatment, harm reduction initiatives, public awareness efforts, and intergovernmental coordination related to HIV prevention, care, and support services;

That the committee hold no fewer than two meetings on this subject;

That witnesses include officials from the Public Health Agency of Canada, the Minister of Health, representatives from Manitoba Health, Indigenous health organizations, front-line community organizations, medical and public health experts, and individuals with lived experience;

And that the committee report its findings and recommendations to the House.

At 4:00 p.m., the meeting was suspended.

At 4:19 p.m., the meeting resumed.

The debate resumed on the motion of Doug Eyolfson as amended.

At 5:25 p.m., the meeting was suspended.

At 5:26 p.m., the meeting resumed.

The debate resumed on the motion of Doug Eyolfson as amended.

At 5:41 p.m., the meeting was suspended.

At 3:36 p.m., on Thursday, June 4, 2026, the meeting resumed in public.

The committee resumed consideration of the study of Canada's pharmaceutical sovereignty.

It has been moved that the committee proceed to the consideration of the subject matter of the request received pursuant to Standing Order 106(4).

The question was put, and it was negatived on the following recorded division:

YEAS: Burton Bailey, Maxime Blanchette-Joncas, Garnett Genuis, Helena Konanz, Dan Mazier— 5;

NAYS: Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Jake Sawatzky, Sonia Sidhu — 6.

The committee resumed consideration of the motion, as amended, of Doug Eyolfson which read as follows:

That, pursuant to Standing Order 108(2), the committee undertake an urgent study on the rising rates of HIV infections in Canada, with particular attention to the recent declaration of a public health emergency by the Province of Manitoba related to the spread of HIV and Syphilis, including the disproportionate impacts in specific regions and populations, including 2SLGBTQI+ communities, on Indigenous peoples, women, rural and northern communities, and individuals experiencing homelessness, mental health challenges, and substance use disorders;

That the study examine federal programs, funding, prevention strategies, access to testing and treatment, harm reduction initiatives, public awareness efforts, and intergovernmental coordination related to HIV prevention, care, and support services;

That the committee hold no fewer than two meetings on this subject;

That witnesses include officials from the Public Health Agency of Canada, the Minister of Health, representatives from Manitoba Health, Indigenous health organizations, front-line community organizations, medical and public health experts, and individuals with lived experience;

And that the committee report its findings and recommendations to the House no later than July 22, 2026;

That, for the purpose of completing this study and ensuring that the report is tabled by July 22, 2026, the committee continue its work through the summer, if necessary, and the Chair be authorized to schedule meetings related to this study after the House rises for the summer;

And that the committee report to the House requesting permission to table this report after the House rises for the summer, if necessary.

At 4:39 p.m., the meeting was suspended.

At 5:03 p.m., the meeting resumed.

At 5:04 p.m., the meeting was suspended.

At 3:57 p.m., on Tuesday, June 9, 2026, the meeting resumed in public.

The committee resumed consideration of the study of Canada pharmaceutical sovereignty and the motion of Doug Eyolfson as amended.

And of the amendment of Garnett Genuis.

RULING BY THE CHAIR

The chair ruled the amendment of Garnett Genuis inadmissible as irrelevant to the main motion because it exceeds its scope and introduces a new proposition which should properly be the subject of a separate substantive motion with notice.

The debate continued on the motion of Doug Eyolfson as amended.

At 4:13 p.m., the meeting was suspended.

At 4:53 p.m., the meeting resumed.

At 4:54 p.m., the meeting was suspended.

At 4:55 p.m., the meeting resumed.

Debate arose on the amendment of Garnett Genuis.

Helena Konanz raised a potential question of privilege concerning the alleged non-compliance by Canada Health Infoway with the committee's order to produce documents.

The Chair reserved his decision.

At 5:37 p.m., the meeting was suspended.

At 4:28 p.m., on Thursday, June 11, 2026, the meeting resumed in public.

The committee resumed consideration of the study of Canada's pharmaceutical sovereignty.

It has been moved that the committee proceed to the consideration of the subject matter of the request received pursuant to Standing Order 106(4).

The question was put, and it was negatived on the following recorded division:

YEAS: Maxime Blanchette-Joncas, Garnett Genuis, Helena Konanz, Dan Mazier, Matt Strauss — 5;

NAYS: Maggie Chi, Doug Eyolfson, Helena Jaczek, Aslam Rana, Salma Zahid, Jake Sawatzky — 6.

The committee resumed consideration of the motion, as amended, of Doug Eyolfson which read as follows:

That, pursuant to Standing Order 108(2), the committee undertake an urgent study on the rising rates of HIV infections in Canada, with particular attention to the recent declaration of a public health emergency by the Province of Manitoba related to the spread of HIV and Syphilis, including the disproportionate impacts in specific regions and populations, including 2SLGBTQI+ communities, on Indigenous peoples, women, rural and northern communities, and individuals experiencing homelessness, mental health challenges, and substance use disorders;

That the study examine federal programs, funding, prevention strategies, access to testing and treatment, harm reduction initiatives, public awareness efforts, and intergovernmental coordination related to HIV prevention, care, and support services;

That the committee hold no fewer than two meetings on this subject;

That witnesses include officials from the Public Health Agency of Canada, the Minister of Health, representatives from Manitoba Health, Indigenous health organizations, front-line community organizations, medical and public health experts, and individuals with lived experience;

And that the committee report its findings and recommendations to the House no later than July 22, 2026;

That, for the purpose of completing this study and ensuring that the report is tabled by July 22, 2026, the committee continue its work through the summer, if necessary, and the Chair be authorized to schedule meetings related to this study after the House rises for the summer;

And that the committee report to the House requesting permission to table this report after the House rises for the summer, if necessary.

and of the amendment of Garnett Genuis moved on Tuesday, June 9, 2026, which read as follows:

That the motion be amended by adding after the words “individuals with lived experience;” the following: “That the committee study PrescribeIT concurrently with this new study, provided that the study on HIV shall not begin until the Minister of Health and Mr. Michael Green have appeared on PrescribeIT, and that the chair be authorized to summon Mr. Green if he declines to appear. That initial witnesses for both studies be submitted by June 11th.”;

And by adding after the words “recommendations to the House” the following: “on HIV and on PrescribeIT”;

And by adding after the words “permission to table this report” the following: “on PrescribeIT and on HIV”.

At 4:39 p.m., the meeting was suspended.

At 5:11 p.m., the meeting resumed.

The debate continued on the amendment of Garnett Genuis.